
US authorities have given emergency authorisation to Swiss pharmaceutical firm Roche for an Ebola test that can take as little as three hours, the company said on Monday.
The US Food and Drug Administration authorised the test for emergency use on patients with signs and symptoms of the deadly virus, Roche said.
"The LightMix Ebola Zaire test is an easy-to-use molecular diagnostic test providing a solution for healthcare professionals to quickly detect the virus and start patient treatment as early as possible," said Roland Diggelmann, chief operations officer of Roche's diagnostics division.
The test, manufactured by German company TIB MOLBIOL GmbH, has also been given the European CE mark indicating it conforms with EU regulations.
Mobile laboratories in the three west African nations hard hit by Ebola -- Guinea, Sierra Leone and Liberia -- currently use expensive and time-consuming tests that can take up to six hours.
Ebola has killed more than 7,500 people over the past year, almost all of them in Liberia, Guinea and Sierra Leone.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor